Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company’s integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company’s Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on…
X:
Facebook:
Instagram:
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
Listen to the daily Bloomberg Technology podcast here:
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:
@Constantinos-Cy
July 3, 2024 at 3:51 pm
Nanotechnology=lung cancer